Li et al(23) confirmed that the inactivation or mutation of the CTCF complex was closely related to the LOI of IGF2 in tumor cells by chromatin immunoprecipitation (CHIP) and chromosome conformation capture (3C) technique (23). This evidence concerns the gene CTCF and neoplasm.